AAAAAA
Results:
1-17
|
Results: 17
Authors:
Vincenti, F
Citation: F. Vincenti, Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen, TRANSPLAN P, 33(4), 2001, pp. 11S-18S
Authors:
Vincenti, F
Citation: F. Vincenti, The role of newer monoclonal antibodies in renal transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1000-1001
Authors:
Vincenti, F
Monaco, A
Grinyo, J
Kinkhabwala, M
Neylan, J
Roza, A
Somberg, K
Citation: F. Vincenti et al., Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1011-1012
Authors:
Vincenti, F
Citation: F. Vincenti, Tacrolimus (FK 506) in kidney transplantation: Five-year survival results of the US multicenter, randomized, comparative trial, TRANSPLAN P, 33(1-2), 2001, pp. 1019-1020
Authors:
Bumgardner, GL
Hardie, I
Johnson, RWG
Lin, A
Nashan, B
Pescovitz, MD
Ramos, E
Vincenti, F
Citation: Gl. Bumgardner et al., Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation., TRANSPLANT, 72(5), 2001, pp. 839-845
Authors:
Bumgardner, GL
Ramos, E
Lin, A
Vincenti, F
Citation: Gl. Bumgardner et al., Daclizumab (humanized anti-IL2r alpha mab) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function, TRANSPLANT, 72(4), 2001, pp. 642-647
Authors:
Vincenti, F
Ramos, E
Brattstrom, C
Cho, S
Ekberg, H
Grinyo, J
Johnson, R
Kuypers, D
Stuart, F
Khanna, A
Navarro, M
Nashan, B
Citation: F. Vincenti et al., Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation, TRANSPLANT, 71(9), 2001, pp. 1282-1287
Authors:
Ekberg, H
Backman, L
Tufveson, G
Tyden, G
Nashan, B
Vincenti, F
Citation: H. Ekberg et al., Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis, TRANSPLAN I, 13(2), 2000, pp. 151-159
Authors:
Chang, GJ
Mahanty, HD
Vincenti, F
Freise, CE
Roberts, JP
Ascher, NL
Stock, PG
Hirose, R
Citation: Gj. Chang et al., A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function, CLIN TRANSP, 14(6), 2000, pp. 550-554
Authors:
Pirsch, J
Bekersky, I
Vincenti, F
Boswell, G
Woodle, ES
Alak, A
Kruelle, M
Fass, N
Facklam, D
Mekki, Q
Citation: J. Pirsch et al., Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: Pharmacokinetics and tolerability, J CLIN PHAR, 40(5), 2000, pp. 527-532
Authors:
Norman, DJ
Vincenti, F
de Mattos, AM
Barry, JM
Levitt, DJ
Wedel, NI
Maia, P
Light, SE
Citation: Dj. Norman et al., Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors, TRANSPLANT, 70(12), 2000, pp. 1707-1712
Authors:
Vincenti, F
Citation: F. Vincenti, Potential of daclizumab in solid organ transplantation, BIODRUGS, 11(5), 1999, pp. 333-341
Authors:
Vincenti, F
Citation: F. Vincenti, Daclizumab: Novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation, TRANSPLAN P, 31(6), 1999, pp. 2206-2207
Authors:
Hariharan, S
Adams, MB
Brennan, DC
Davis, CL
First, MR
Johnson, CP
Ouseph, R
Peddi, VR
Pelz, C
Roza, AM
Vincenti, F
George, V
Citation: S. Hariharan et al., Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry, TRANSPLAN P, 31(1-2), 1999, pp. 223-224
Authors:
Vincenti, F
Grinyo, J
Ramos, E
Nashan, B
Stuart, F
Kuypers, D
Brattstrom, C
Cho, S
Ekberg, H
Johnson, R
Citation: F. Vincenti et al., Can antibody prophylaxis allow sparing of other immunosuppressives?, TRANSPLAN P, 31(1-2), 1999, pp. 1246-1248
Authors:
Hariharan, S
Adams, MB
Brennan, DC
Davis, CL
First, MR
Johnson, CP
Ouseph, R
Peddi, VR
Pelz, CJ
Roza, AM
Vincenti, F
George, V
Citation: S. Hariharan et al., Recurrent and de novo glomerular disease after renal transplantation - A report from Renal Allograft Disease Registry (RADR), TRANSPLANT, 68(5), 1999, pp. 635-641
Authors:
Solez, K
Vincenti, F
Filo, RS
Citation: K. Solez et al., Histopathologic findings from 2-year protocol biopsies from a US multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group, TRANSPLANT, 66(12), 1998, pp. 1736-1740
Risultati:
1-17
|